Connect public, paid and private patent data with Google Patents Public Datasets

Cardiac disease treatment and device

Download PDF

Info

Publication number
US20010029314A1
US20010029314A1 US09880576 US88057601A US2001029314A1 US 20010029314 A1 US20010029314 A1 US 20010029314A1 US 09880576 US09880576 US 09880576 US 88057601 A US88057601 A US 88057601A US 2001029314 A1 US2001029314 A1 US 2001029314A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
heart
jacket
lower
during
fig
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09880576
Inventor
Clifton Alferness
Jai Raman
John Power
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acorn Cardiovascular Inc
Original Assignee
Acorn Cardiovascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2478Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • A61F2/2481Devices outside the heart wall, e.g. bags, strips or bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0068Implantable repair or support meshes, e.g. hernia meshes having a special mesh pattern

Abstract

A jacket of biological compatible material has an internal volume dimensioned for an apex of the heart to be inserted into the volume and for the jacket to be slipped over the heart. The jacket has a longitudinal dimension between upper and lower ends sufficient for the jacket to surround a lower portion of the heart with the jacket surrounding a valvular annulus of the heart and further surrounding the lower portion to cover at least the ventricular lower extremities of the heart. The jacket is adapted to be secured to the heart with the jacket surrounding at least the valvular annulus and the ventricular lower extremities. The jacket is adjustable on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain circumferential expansion of the heart beyond the maximum adjusted volume during diastole and to permit unimpeded contraction of the heart during systole.

Description

    BACKGROUND OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    The present invention pertains to a device and method for treating heart disease. More particularly, the present invention is directed to a method and device for treating congestive heart disease and related valvular dysfunction.
  • [0003]
    2. Description of the Prior Art
  • [0004]
    Congestive heart disease is a progressive and debilitating illness. The disease is characterized by a progressive enlargement of the heart.
  • [0005]
    As the heart enlarges, the heart is performing an increasing amount of work in order to pump blood each heart beat. In time, the heart becomes so enlarged the heart cannot adequately supply blood. An afflicted patient is fatigued, unable to perform even simple exerting tasks and experiences pain and discomfort. Further, as the heart enlarges, the internal heart valves cannot adequately close. This impairs the function of the valves and further reduces the heart's ability to supply blood.
  • [0006]
    Causes of congestive heart disease are not fully known. In certain instances, congestive heart disease may result from viral infections. In such cases, the heart may enlarge to such an extent that the adverse consequences of heart enlargement continue after the viral infection has passed and the disease continues its progressively debilitating course.
  • [0007]
    Patients suffering from congestive heart disease are commonly grouped into four classes (i.e., Classes I, II, III and IV). In the early stages (e.g., Classes I and II), drug therapy is the commonly proscribed treatment. Drug therapy treats the symptoms of the disease and may slow the progression of the disease. Importantly, there is no cure for congestive heart disease. Even with drug therapy, the disease will progress. Further, the drugs may have adverse side effects.
  • [0008]
    Presently, the only permanent treatment for congestive heart disease is heart transplant. To qualify, a patient must be in the later stage of the disease (e.g., Classes III and IV with Class IV patients given priority for transplant). Such patients are extremely sick individuals. Class III patients have marked physical activity limitations and Class IV patients are symptomatic even at rest.
  • [0009]
    Due to the absence of effective intermediate treatment between drug therapy and heart transplant, Class III and IV patients will have suffered terribly before qualifying for heart transplant. Further, after such suffering, the available treatment is unsatisfactory. Heart transplant procedures are very risky, extremely invasive and expensive and only shortly extend a patient's life. For example, prior to transplant, a Class IV patient may have a life expectancy of 6 months to one-year. Heart transplant may improve the expectancy to about five years.
  • [0010]
    Unfortunately, not enough hearts are available for transplant to meet the needs of congestive heart disease patients. In the United States, in excess of 35,000 transplant candidates compete for only about 2,000 transplants per year. A transplant waiting list is about 8-12 months long on average and frequently a patient may have to wait about 1-2 years for a donor heart. While the availability of donor hearts has historically increased, the rate of increase is slowing dramatically. Even if the risks and expense of heart transplant could be tolerated, this treatment option is becoming increasingly unavailable. Further, many patient's do not qualify for heart transplant for failure to meet any one of a number of qualifying criteria.
  • [0011]
    Congestive heart failure has an enormous societal impact. In the United States alone, about five million people suffer from the disease (Classes I through IV combined). Alarmingly, congestive heart failure is one of the most rapidly accelerating diseases (about 400,000 new patients in the United States each year). Economic costs of the disease have been estimated at $38 billion annually.
  • [0012]
    Not surprising, substantial effort has been made to find alternative treatments for congestive heart disease. Recently, a new surgical procedure has been developed. Referred to as the Batista procedure, the surgical technique includes dissecting and removing portions of the heart in order to reduce heart volume. This is a radical new and experimental procedure subject to substantial controversy. Furthermore, the procedure is highly invasive, risky and expensive and commonly includes other expensive procedures (such as a concurrent heart valve replacement). Also, the treatment is limited to Class IV patients and, accordingly, provides no hope to patients facing ineffective drug treatment prior to Class IV. Finally, if the procedure fails, emergency heart transplant is the only available option.
  • [0013]
    Clearly, there is a need for alternative treatments applicable to both early and later stages of the disease to either stop the progressive nature of the disease or more drastically slow the progressive nature of congestive heart disease. Unfortunately, currently developed options are experimental, costly and problematic.
  • [0014]
    Cardiomyoplasty is a recently developed treatment for earlier stage congestive heart disease (e.g., as early as Class III dilated cardiomyopathy). In this procedure, the latissimus dorsi muscle (taken from the patient's shoulder) is wrapped around the heart and chronically paced synchronously with ventricular systole. Pacing of the muscle results in muscle contraction to assist the contraction of the heart during systole.
  • [0015]
    While cardiomyoplasty has resulted in symptomatic improvement, the nature of the improvement is not understood. For example, one study has suggested the benefits of cardiomyoplasty are derived less from active systolic assist than from remodeling, perhaps because of an external elastic constraint. The study suggests an elastic constraint (i.e., a non-stimulated muscle wrap or an artificial elastic sock placed around the heart) could provide similar benefits. Kass et al., Reverse Remodeling From Cardiomyoplasty In Human Heart Failure: External Constraint Versus Active Assist, 91 Circulation 2314-2318 (1995).
  • [0016]
    Even though cardiomyoplasty has demonstrated symptomatic improvement, studies suggest the procedure only minimally improves cardiac performance. The procedure is highly invasive requiring harvesting a patient's muscle and an open chest approach (i.e., sternotomy) to access the heart. Furthermore, the procedure is expensive—especially those using a paced muscle. Such procedures require costly pacemakers. The cardiomyoplasty procedure is complicated. For example, it is difficult to adequately wrap the muscle around the heart with a satisfactory fit. Also, if adequate blood flow is not maintained to the wrapped muscle, the muscle may necrose. The muscle may stretch after wrapping reducing its constraining benefits and is generally not susceptible to postoperative adjustment. Finally, the muscle may fibrose and adhere to the heart causing undesirable constraint on the contraction of the heart during systole.
  • [0017]
    In addition to cardiomyoplasty, mechanical assist devices have been developed as intermediate procedures for treating congestive heart disease. Such devices include left ventricular assist devices (“LVAD”) and total artificial hearts (“TAH”). An LVAD includes a mechanical pump for urging blood flow from the left ventricle and into the aorta. An example of such is shown in U.S. Pat. No. 4,995,857 to Arnold dated Feb. 26, 1991. LVAD surgeries are still in U.S. clinical trials and not generally available. Such surgeries are expensive. The devices are at risk of mechanical failure and frequently require external power supplies. TAH devices, such as the celebrated Jarvik heart, are used as temporary measures while a patient awaits a donor heart for transplant.
  • [0018]
    Other attempts at cardiac assist devices are found in U.S. Pat. No. 4,957,477 to Lundback dated Sep. 18, 1990, U.S. Pat. No. 5,131,905 to Grooters dated Jul. 21, 1992 and U.S. Pat. No. 5,256,132 to Snyders dated Oct. 26, 1993. Both of the Grooters and Snyders patents teach cardiac assist devices which pump fluid into chambers opposing the heart to assist systolic contractions of the heart. The Lundback patent teaches a double-walled jacket surrounding the heart. A fluid fills a chamber between the walls of the jacket. The inner wall is positioned against the heart and is pliable to move with the heart. Movement of the heart during beating displaces fluid within the jacket chamber.
  • [0019]
    Commonly assigned U.S. Pat. No. 5,702,343 to Alferness dated Dec. 30, 1997 teaches a jacket to constrain cardiac expansion during diastole. The present invention pertains to improvements to the invention disclosed in the '343 patent.
  • SUMMARY OF THE INVENTION
  • [0020]
    According to a preferred embodiment of the present invention, a method and device are disclosed for treating congestive heart disease and related cardiac complications such as valvular disorders. The invention includes a jacket of biologically compatible material. The jacket has an internal volume dimensioned for an apex of the heart to be inserted into the volume and for the jacket to be slipped over the heart. The jacket has a longitudinal dimension between upper and lower ends sufficient for the jacket to surround a lower portion of the heart with the jacket surrounding a valvular annulus of the heart and further surrounding the lower portion to cover at least the ventricular lower extremities of the heart. The jacket is adapted to be secured to the heart with the jacket surrounding at least the valvular annulus and the ventricular lower extremities. The jacket is adjustable on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain circumferential expansion of the heart beyond the maximum adjusted volume during diastole and to permit unimpeded contraction of the heart during systole. In one embodiment, a lower end of the jacket can be secured to the patients diaphragm after placement around the heart.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0021]
    [0021]FIG. 1 is a schematic cross-sectional view of a normal, healthy human heart shown during systole;
  • [0022]
    [0022]FIG. 1A is the view of FIG. 1 showing the heart during diastole;
  • [0023]
    [0023]FIG. 1B is a view of a left ventricle of a healthy heart as viewed from a septum and showing a mitral valve;
  • [0024]
    [0024]FIG. 2 is a schematic cross-sectional view of a diseased human hears shown during systole;
  • [0025]
    [0025]FIG. 2A is the view of FIG. 2 showing the heart during diastole;
  • [0026]
    [0026]FIG. 2B is the view of FIG. 1B showing a diseased heart;
  • [0027]
    [0027]FIG. 3 is a perspective view of a first embodiment of a cardiac constraint device according to the present invention;
  • [0028]
    [0028]FIG. 3A is a side elevation view of a diseased heart in diastole with the device of FIG. 3 in place;
  • [0029]
    [0029]FIG. 4 is a perspective view of a second embodiment of a cardiac constraint device according to the present invention;
  • [0030]
    [0030]FIG. 4A is a side elevation view of a diseased heart in diastole with the device of FIG. 4 in place;
  • [0031]
    [0031]FIG. 5 is a cross-sectional view of a device of the present invention overlying a myocardium and with the material of the device gathered for a snug fit;
  • [0032]
    [0032]FIG. 6 is an enlarged view of a knit construction of the device of the present invention in a rest state; and
  • [0033]
    [0033]FIG. 7 is a schematic view of the material of FIG. 6.
  • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0034]
    With initial reference to FIGS. 1 and 1A, a normal, healthy human heart H′ is schematically shown in cross-section and will now be described in order to facilitate an understanding of the present invention. In FIG. 1, the heart H′ is shown during systole (i.e., high left ventricular pressure). In FIG. 1A, the heart H′ is shown during diastole (i.e., low left ventricular pressure).
  • [0035]
    The heart H′ is a muscle having an outer wall or myocardium MYO′ and an internal wall or septum S′. The myocardium MYO′ and septum S′ define four internal heart chambers including a right atrium RA′, a left atrium LA′, a right ventricle RV′ and a left ventricle LV′. The heart H′ has a length measured along a longitudinal axis AA′-BB′ from an upper end or base B′ to a lower end or apex A′.
  • [0036]
    The right and left atria RA′, LA′ reside in an upper portion UP′ of the heart H′ adjacent the base B′. The right and left ventricles RV′, LV′ reside in a lower portion LP′ of the heart H′ adjacent the apex A′. The ventricles RV′, LV′ terminate at ventricular lower extremities LE′ adjacent the apex A′ and spaced therefrom by the thickness of the myocardium MYO′.
  • [0037]
    Due to the compound curves of the upper and lower portions UP′, LP′, the upper and lower portions UP′, LP′ meet at a circumferential groove commonly referred to as the A-V groove AVG′. Extending away from the upper portion UP′ are a plurality of major blood vessels communicating with the chambers RA′, RV′, LA′, LV′. For ease of illustration, only the superior vena cava SVC′ and a left pulmonary vein LPV′ are shown as being representative.
  • [0038]
    The heart H′ contains valves to regulate blood flow between the chambers RA′, RV′, LA′, LV′ and between the chambers and the major vessels (e.g., the superior vena cava SVC′ and a left pulmonary vein LPV′). For ease of illustration, not all of such valves are shown. Instead, only the tricuspid valve TV′ between the right atrium RA′ and right ventricle RV′ and the mitral valve MV′ between the left atrium LA′ and left ventricle LV′ are shown as being representative.
  • [0039]
    The valves are secured, in part, to the myocardium MYO′ in a region of the lower portion LP′ adjacent the A-V groove AVG′ and referred to as the valvular annulus VA′. The valves TV′ and MV′ open and close through the beating cycle of the heart H.
  • [0040]
    [0040]FIGS. 1 and 1A show a normal, healthy heart H′ during systole and diastole, respectively. During systole (FIG. 1), the myocardium MYO′ is contracting and the heart assumes a shape including a generally conical lower portion LP′. During diastole (FIG. 1A), the heart H′ is expanding and the conical shape of the lower portion LP′ bulges radially outwardly (relative to axis AA′-BB′).
  • [0041]
    The motion of the heart H′ and the variation in the shape of the heart H′ during contraction and expansion is complex. The amount of motion varies considerably throughout the heart H′. The motion includes a component which is parallel to the axis AA′-BB′ (conveniently referred to as longitudinal expansion or contraction). The motion also includes a component perpendicular to the axis AA′-BB′ (conveniently referred to as circumferential expansion or contraction).
  • [0042]
    Having described a healthy heart H′ during systole (FIG. 1) and diastole (FIG. 1A), comparison can now be made with a heart deformed by congestive heart disease. Such a heart H is shown in systole in FIG. 2 and in diastole in FIG. 2A. All elements of diseased heart H are labeled identically with similar elements of healthy heart H′ except only for the omission of the apostrophe in order to distinguish diseased heart H from healthy heart H′.
  • [0043]
    Comparing FIGS. 1 and 2 (showing hearts H′ and H during systole), the lower portion LP of the diseased heart H has lost the tapered conical shape of the lower portion LP′ of the healthy heart H′. Instead, the lower portion LP of the diseased heart H bulges outwardly between the apex A and the A-V groove AVG. So deformed, the diseased heart H during systole (FIG. 2) resembles the healthy heart H′ during diastole (FIG. 1A). During diastole (FIG. 2A), the deformation is even more extreme.
  • [0044]
    As a diseased heart H enlarges from the representation of FIGS. 1 and 1A to that of FIGS. 2 and 2A, the heart H becomes a progressively inefficient pump. Therefore, the heart H requires more energy to pump the same amount of blood. Continued progression of the disease results in the heart H being unable to supply adequate blood to the patient's body and the patient becomes symptomatic insufficiency.
  • [0045]
    For ease of illustration, the progression of congestive heart disease has been illustrated and described with reference to a progressive enlargement of the lower portion LP of the heart H. While such enlargement of the lower portion LP is most common and troublesome, enlargement of the upper portion UP may also occur.
  • [0046]
    In addition to cardiac insufficiency, the enlargement of the heart H can lead to valvular disorders. As the circumference of the valvular annulus VA increases, the leaflets of the valves TV and MV may spread apart. After a certain amount of enlargement, the spreading may be so severe the leaflets cannot completely close (as illustrated by the mitral valve MV in FIG. 2A). Incomplete closure results in valvular regurgitation contributing to an additional degradation in cardiac performance. While circumferential enlargement of the valvular annulus VA may contribute to valvular dysfunction as described, the separation of the valve leaflets is most commonly attributed to deformation of the geometry of the heart H. This is best described with reference to FIGS. 1B and 2B.
  • [0047]
    [0047]FIGS. 1B and 2B show a healthy and diseased heart, respectively, left ventricle LV′, LV during systole as viewed from the septum (not shown in FIGS. 1B and 2B). In a healthy heart H′, the leaflets MVL′ of the mitral valve MV′ are urged closed by left ventricular pressure. The papillary muscles PM′, PM are connected to the heart wall MYO′, MYO, near the lower ventricular extremities LE′, LE. The papillary muscles PM′, PM pull on the leaflets MVL′, MVL via connecting chordae tendineae CT′, CT. Pull of the leaflets by the papillary muscles functions to prevent valve leakage in the normal heart by holding the valve leaflets in a closed position during systole. In the significantly diseased heart H, the leaflets of the mitral valve may not close sufficiently to prevent regurgitation of blood from the ventricle LV to the atrium during systole.
  • [0048]
    As shown in FIG. 1B, the geometry of the healthy heart H′ is such that the myocardium MYO′, papillary muscles PM′ and chordae tendineae CT′ cooperate to permit the mitral valve MV′ to fully close. However, when the myocardium MYO bulges outwardly in the diseased heart H (FIG. 2B), the bulging results in displacement of the papillary muscles PM. This displacement acts to pull the leaflets MVL to a displaced position such that the mitral valve cannot fully close.
  • [0049]
    Having described the characteristics and problems of congestive heart disease, the treatment method and apparatus of the present invention will now be described.
  • [0050]
    In general, a jacket of the invention is configured to surround the myocardium MYO. As used herein, “surround” means that jacket provides reduced expansion of the heart wall during diastole by applying constraining surfaces at least at diametrically opposing aspects of the heart. In some preferred embodiments disclosed herein, the diametrically opposed surfaces are interconnected, for example, by a continuous material that can substantially encircle the external surface of the heart.
  • [0051]
    With reference now to FIGS. 3, 3A, 4 and 4A, the device of the present invention is shown as a jacket 10 of flexible, biologically compatible material. The jacket 10 is an enclosed knit material having upper and lower ends 12, 14. The jacket 10, 10′ defines an internal volume 16, 16′ which is completely enclosed but for the open ends 12, 12′ and 14′. In the embodiment of FIG. 3, lower end 14 is closed. In the embodiment of FIG. 4, lower end 14′ is open. In both embodiments, upper ends 12, 12′ are open. Throughout this description, the embodiment of FIG. 3 will be discussed. Elements in common between the embodiments of FIGS. 3 and 4 are numbered identically with the addition of an apostrophe to distinguish the second embodiment and such elements need not be separately discussed.
  • [0052]
    The jacket 10 is dimensioned with respect to a heart H to be treated. Specifically, the jacket 10 is sized for the heart H to be constrained within the volume 16. The jacket 10 can be slipped around the heart H. The jacket 10 has a length L between the upper and lower ends 12, 14 sufficient for the jacket 10 to constrain the lower portion LP. The upper end 12 of the jacket 10 extends at least to the valvular annulus VA and further extends to the lower portion LP to constrain at least the lower ventricular extremities LE.
  • [0053]
    Since enlargement of the lower portion LP is most troublesome, in a preferred embodiment, the jacket 10 is sized so that the upper end 12 can reside in the A-V groove AVG. Where it is desired to constrain enlargement of the upper portion UP, the jacket 10 may be extended to cover the upper portion UP.
  • [0054]
    Sizing the jacket 10 for the upper end 12 to terminate at the A-V groove AVG is desirable for a number of reasons. First, the groove AVG is a readily identifiable anatomical feature to assist a surgeon in placing the jacket 10. By placing the upper end 12 in the A-V groove AVG, the surgeon is assured the jacket 10 will provide sufficient constraint at the valvular annulus VA. The A-V groove AVG and the major vessels act as natural stops for placement of the jacket 10 while assuring coverage of the valvular annulus VA. Using such features as natural stops is particularly beneficial in minimally invasive surgeries where a surgeon's vision may be obscured or limited.
  • [0055]
    When the parietal pericardium is opened, the lower portion LP is free of obstructions for applying the jacket 10 over the apex A. If, however, the parietal pericardium is intact, the diaphragmatic attachment to the parietal pericardium inhibits application of the jacket over the apex A of the heart. In this situation, the jacket can be opened along a line extending from the upper end 12′ to the lower end 14′ of jacket 10′. The jacket can then be applied around the pericardial surface of the heart and the opposing edges of the opened line secured together after placed on the heart. Systems for securing the opposing edges are disclosed in, for example, U.S. Pat. No. 5,702,343, the entire disclosure of which is incorporated herein by reference. The lower end 14′ can then be secured to the diaphragm or associated tissues using, for example, sutures, staples, etc.
  • [0056]
    In the embodiment of FIGS. 3 and 3A, the lower end 14 is closed and the length L is sized for the apex A of the heart H to be received within the lower end 14 when the upper end 12 is placed at the A-V groove AVG. In the embodiment of FIGS. 4 and 4A, the lower end 14′ is open and the length L′ is sized for the apex A of the heart H to protrude beyond the lower end 14′ when the upper end 12′ is placed at the A-V groove AVG. The length L′ is sized so that the lower end 14′ extends beyond the lower ventricular extremities LE such that in both of jackets 10, 10′, the myocardium MYO surrounding the ventricles RV, LV is in direct opposition to material of the jacket 10, 10′. Such placement is desirable for the jacket 10, 10′ to present a constraint against enlargement of the ventricular walls of the heart H.
  • [0057]
    After the jacket 10 is positioned on the heart H as described above, the jacket 10 is secured to the heart. Preferably, the jacket 10 is secured to the heart H through sutures. The jacket 10 is sutured to the heart H at suture locations S circumferentially spaced along the upper end 12. While a surgeon may elect to add additional suture locations to prevent shifting of the jacket 10 after placement, the number of such locations S is preferably limited so that the jacket 10 does not restrict contraction of the heart H during systole.
  • [0058]
    To permit the jacket 10 to be easily placed on the heart H, the volume and shape of the jacket 10 are larger than the lower portion LP during diastole. So sized, the jacket 10 may be easily slipped around the heart H. Once placed, the jacket's volume and shape are adjusted for the jacket 10 to snugly conform to the external geometry of the heart H during diastole. Such sizing is easily accomplished due to the knit construction of the jacket 10. For example, excess material of the jacket 10 can be gathered and sutured S″ (FIG. 5) to reduce the volume of the jacket 10 and conform the jacket 10 to the shape of the heart H during diastole. Such shape represents a maximum adjusted volume. The jacket 10 constrains enlargement of the heart H beyond the maximum adjusted volume while preventing restricted contraction of the heart H during systole. As an alternative to gathering of FIG. 5, the jacket 10 can be provided with other ways of adjusting volume. For example, as disclosed in U.S. Pat. No. 5,702,343, the jacket can be provided with a slot. The edges of the slot can be drawn together to reduce the volume of the jacket.
  • [0059]
    The jacket 10 is adjusted to a snug fit on the heart H during diastole. Care is taken to avoid tightening the jacket 10 too much such that cardiac function is impaired. During diastole, the left ventricle LV fills with blood. If the jacket 10 is too tight, the left ventricle LV cannot adequately expand and left ventricular pressure will rise. During the fitting of the jacket 10, the surgeon can monitor left ventricular pressure. For example, a well-known technique for monitoring so-called pulmonary wedge pressure uses a catheter placed in the pulmonary artery. The wedge pressure provides an indication of filling pressure in the left atrium LA and left ventricle LV. While minor increases in pressure (e.g., 2-3 mm Hg) can be tolerated, the jacket 10 is snugly fit on the heart H but not so tight as to cause a significant increase in left ventricular pressure during diastole.
  • [0060]
    As mentioned, the jacket 10 is constructed from a knit, biocompatible material. The knit 18 is illustrated in FIG. 6. Preferably, the knit is a so-called “Atlas knit” well known in the fabric industry. The Atlas knit is described in Paling, Warp Knitting Technology, p. 111, Columbine Press (Publishers) Ltd., Buxton, Great Britain (1970).
  • [0061]
    The Atlas knit is a knit of fibers 20 having directional expansion properties. More specifically, the knit 18, although formed of generally inelastic fibers 20, permits a construction of a flexible fabric at least slightly expandable beyond a rest state. FIG. 6 illustrates the knit 18 in a rest state. The fibers 20 of the fabric 18 are woven into two sets of fiber strands 21 a, 21 b having longitudinal axes Xa and Xb. The strands 21 a, 21 b are interwoven to form the fabric 18 with strands 21 a generally parallel and spaced-apart and with strands 21 b generally parallel and spaced-apart.
  • [0062]
    For ease of illustration, fabric 18 is schematically shown in FIG. 7 with the axis of the strands 21 a, 21 b only being shown. The strands 21 a, 21 b are interwoven with the axes Xa and Xb defining a diamond-shaped open cell 23 having diagonal axes Am. In a preferred embodiment, the axes Am are 5 mm in length when the fabric 18 is at rest and not stretched. The fabric 18 can stretch in response to a force. For any given force, the fabric 18 stretches most when the force is applied parallel to the diagonal axes Am. The fabric 18 stretches least when the force is applied parallel to the strand axes Xa and Xb. The jacket 10 is constructed for the material of the knit to be directionally aligned for a diagonal axis Am. to be parallel to the heart's longitudinal axis AA-BB
  • [0063]
    While the jacket 10 is expandable due to the above described knit pattern, the fibers 20 of the knit 18 are preferably non-expandable. While all materials expand to at least a small amount, the fibers 20 are preferably formed of a material with a low modulus of elasticity. In response to the low pressures in the heart H during diastole, the fibers 20 are non-elastic. In a preferred embodiment, the fibers are 70 Denier polyester. While polyester is presently preferred, other suitable materials include polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polypropylene and stainless steel.
  • [0064]
    The knit material has numerous advantages. Such a material is flexible to permit unrestricted movement of the heart H (other than the desired constraint on circumferential expansion). The material is open defining a plurality of interstitial spaces for fluid permeability as well as minimizing the amount of surface area of direct contact between the heart H and the material of the jacket 10 (thereby minimizing areas of irritation or abrasion) to minimize fibrosis and scar tissue.
  • [0065]
    The open areas of the knit construction also allows for electrical connection between the heart and surrounding tissue for passage of electrical current to and from the heart. For example, although the knit material is an electrical insulator, the open knit construction is sufficiently electrically permeable to permit the use of trans-chest defibrillation of the heart. Also, the open, flexible construction permits passage of electrical elements (e.g., pacer leads) through the jacket. Additionally, the open construction permits other procedures, e.g., coronary bypass, to be performed without removal of the jacket.
  • [0066]
    A large open area for cells 23 is desirable to minimize the amount of surface area of the heart H in contact with the material of the jacket 10 (thereby reducing fibrosis). However, if the cell area 23 is too large, localized aneurysm can form. Also, a strand 21 a, 21 b can overly a coronary vessel with sufficient force to partially block the vessel. A smaller cell size increases the number of strands thereby decreasing the restricting force per strand. Preferably, a maximum cell area is no greater than about 6.45 cm2 (about 2.54 cm by 2.54 cm) and, more preferably, is about 0.25 cm2 (about 0.5 cm by 0.5 cm). The maximum cell area is the area of a cell 23 after the material of the jacket 10 is fully stretched and adjusted to the maximum adjusted volume on the heart H as previously described.
  • [0067]
    The fabric 18 is preferably tear and run resistant. In the event of a material defect or inadvertent tear, such a defect or tear is restricted from propagation by reason of the knit construction.
  • [0068]
    With the foregoing, a device and method have been taught to treat cardiac disease. The jacket 10 constrains further undesirable circumferential enlargement of the heart while not impeding other motion of the heart H. With the benefits of the present teachings, numerous modifications are possible. For example, the jacket 10 need not be directly applied to the epicardium (i.e., outer surface of the myocardium) but could be placed over the parietal pericardium. Further, an anti-fibrosis lining (such as a PTFE coating on the fibers of the knit) could be placed between the heart H and the jacket 10. Alternatively, the fibers 20 can be coated with PTFE.
  • [0069]
    The jacket 10 is low-cost, easy to place and secure, and is susceptible to use in minimally invasive procedures. The thin, flexible fabric 18 permits the jacket 10 to be collapsed and passed through a small diameter tube in a minimally invasive procedure.
  • [0070]
    The jacket 10 can be used in early stages of congestive heart disease. For patients facing heart enlargement due to viral infection, the jacket 10 permits constraint of the heart H for a sufficient time to permit the viral infection to pass. In addition to preventing further heart enlargement, the jacket 10 treats valvular disorders by constraining circumferential enlargement of the valvular annulus and deformation of the ventricular walls.
  • [0071]
    The jacket 10, including the knit construction, freely permits longitudinal and circumferential contraction of the heart H (necessary for heart function). Unlike a solid wrap (such as a muscle wrap in a cardiomyoplasty procedure), the fabric 18 does not impede cardiac contraction. After fitting, the jacket 10 is inelastic to prevent further heart enlargement while permitting unrestricted inward movement of the ventricular walls. The open cell structure permits access to coronary vessels for bypass procedures subsequent to placement of the jacket 10. Also, in cardiomyoplasty, the latissimus dorsi muscle has a variable and large thickness (ranging from about 1 mm to 1 cm). The material of the jacket 10 is uniformly thin (less than 1 mm thick). The thin wall construction is less susceptible to fibrosis and minimizes interference with cardiac contractile function.
  • [0072]
    Animal test studies on the device show the efficacy of the invention. Test animals were provided with the device 10 of FIG. 3. The animals' hearts were rapidly paced to induce enlargement. After six weeks, animals without the device experienced significant heart enlargement while those with the device experienced no significant enlargement. Further, animals with the device had significantly reduced mitral valve regurgitation.
  • [0073]
    In addition to the foregoing, the present invention can be used to reduce heart size at the time of placement in addition to preventing further enlargement. For example, the device can be placed on the heart and sized snugly to urge the heart to a reduced size. More preferably, the heart size can be reduced at the time of jacket placement through drugs (e.g., dobutamine, dopamine or epinephrine or any other positive inotropic agents) to reduce the heart size. The jacket of the present invention is then snugly placed on the reduced sized heart and prevents enlargement beyond the reduced size.
  • [0074]
    From the foregoing, a low cost, reduced risk method and device are taught to treat cardiac disease. The invention is adapted for use with both early and later stage congestive heart disease patients. The invention reduces the enlargement rate of the heart as well as reducing cardiac valve regurgitation.

Claims (17)

What is claimed is:
1. A device for treating cardiac disease of a heart having a longitudinal axis from an apex to a base and having an upper portion and a lower portion divided by an A-V groove, said heart including a valvular annulus adjacent said A-V groove and ventricular lower extremities adjacent said apex, the device comprising:
a jacket of flexible material of knit construction defining a volume between an open upper end and a lower end, said jacket dimensioned for said apex of said heart to be inserted into said volume through said open upper end and for said jacket to be slipped over said heart, said jacket further dimensioned for said jacket to have a longitudinal dimension between said upper and lower ends sufficient for said jacket to constrain said lower portion with said jacket constraining said valvular annulus and further constraining said ventricular lower extremities;
said jacket adapted to be secured to said heart with said jacket having portions disposed on opposite sides of the heart between said valvular annulus and said ventricular lower extremities; and
said jacket adapted to be adjusted on said heart to snugly conform to an external geometry of said heart and assume a maximum adjusted volume for said jacket to constrain circumferential expansion of said heart beyond said maximum adjusted volume during diastole and permit substantially unimpeded contraction of said heart during systole.
2. A device according to
claim 2
wherein:
said material is expandable along a first material axis in response to a force parallel to said first axis greater than an expansion of said material along a second axis in response to a force of equal magnitude parallel to said second axis;
said material oriented for said first axis to extend circumferentially around said longitudinal dimension.
3. A device according to
claim 1
wherein said jacket is open at said lower end.
4. A device according to
claim 1
wherein said jacket is closed at said lower end.
5. A device according to
claim 1
wherein said material is run resistant.
6. A device according to
claim 5
wherein:
said material is expandable along a first material axis in response to a force parallel to said first axis greater than an expansion of said material along a perpendicular second axis in response to a force of equal magnitude parallel to said second axis;
said material oriented for said first axis to extend from said upper end of said jacket toward said lower end.
7. A device according to
claim 1
wherein said material is sufficiently flexible to gather excess amounts of said material following placement of said jacket over said heart to snugly conform said material to an external geometry of said heart.
8. A device according to
claim 5
wherein said material is sufficiently flexible to gather excess amounts of said material following placement of said jacket over said heart to snugly conform said material to an external geometry of said heart.
9. A device according to
claim 1
wherein said material is selected from a group of polytetrafluoroethylene, expanded polytetrafluoroethylene, polypropylene, polyester or stainless steel.
10. A device according to
claim 5
wherein said material is formed of elongated fibers selected from a group of polytetrafluoroethylene, expanded polytetrafluoroethylene, polypropylene, polyester or stainless steel.
11. A device according to
claim 1
wherein said jacket is sized to at least partially cover and constrain said upper portion.
12. A device according to
claim 1
further comprising a liner sized and positioned to be disposed between said heart and said jacket, said liner formed of an anti-fibrotic material.
13. A device according to
claim 1
wherein the jacket is electrically permeable.
14. A device for treating cardiac disease of a heart having a longitudinal axis from an apex to a base and having an upper portion and a lower portion divided by an A-V groove, said heart including a valvular annulus adjacent said A-V groove and ventricular lower extremities adjacent said apex, the device comprising:
a jacket of flexible, electrically permeable material adapted to be secured to said heart with said jacket having portions disposed on opposite sides of the heart between said valvular annulus and said ventricular lower extremities; and
said jacket adapted to be adjusted on said heart to snugly conform to an external geometry of said heart and assume a maximum adjusted volume for said jacket to constrain circumferential expansion of said heart beyond said maximum adjusted volume during diastole and permit unimpeded contraction of said heart during systole.
15. A device according to
claim 2
wherein said jacket circumferentially surrounds said heart.
16. A method for treating cardiac disease of a patient's heart, said method comprising:
surgically accessing said patient's heart and diaphragm;
placing a jacket around said heart, said jacket comprising a biomedical material having an upper end and a lower end;
adjusting said jacket on said heart to snugly conform to an external geometry of said heart and assume a maximum adjusted volume for said jacket to constrain circumferential expansion of said heart beyond said maximum adjusted volume during diastole and permitting unimpeded contraction of said heart during systole; and
securing said lower end of said jacket to said diaphragm.
17. A method according to
claim 16
wherein said lower end of said jacket is secured to said diaphragm using sutures.
US09880576 1998-07-13 2001-06-13 Cardiac disease treatment and device Abandoned US20010029314A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09114510 US6123662A (en) 1998-07-13 1998-07-13 Cardiac disease treatment and device
US09565621 US6537203B1 (en) 1998-07-13 2000-05-04 Cardiac disease treatment and device
US09880576 US20010029314A1 (en) 1998-07-13 2001-06-13 Cardiac disease treatment and device

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US09880576 US20010029314A1 (en) 1998-07-13 2001-06-13 Cardiac disease treatment and device
US10251193 US6896652B2 (en) 1998-07-13 2002-09-20 Cardiac disease treatment and device
US10794311 US6997865B2 (en) 1998-07-13 2004-03-05 Cardiac support device with anti-fibrosis lining
US10794319 US7022064B2 (en) 1998-07-13 2004-03-05 Cardiac support with controlled ventricular pressure
US10809961 US7025719B2 (en) 1998-07-13 2004-03-26 Metallic cardiac support device
US10810096 US7153258B2 (en) 1998-07-13 2004-03-26 Cardiac support disease with anti-fibrosis coating
US10809962 US7578784B2 (en) 1998-07-13 2004-03-26 Cardiac support device with differential expansion
US10810133 US20040181125A1 (en) 1998-07-13 2004-03-26 Cardiac disease treatment and device
US11329808 US7651461B2 (en) 1998-07-13 2006-01-10 Cardiac support with metallic structure
US11451209 US7575547B2 (en) 1998-07-13 2006-06-12 Cardiac support device with anti-fibrosis coating
US11469224 US20070004962A1 (en) 1996-10-02 2006-08-31 Cardiac support device with differential compliance
US12633434 US20100076256A1 (en) 1998-07-13 2009-12-08 Cardiac disease treatment and device
US12719553 US8277372B2 (en) 1998-07-13 2010-03-08 Cardiac support device with differential compliance
US12987430 US20110106193A1 (en) 1998-07-13 2011-01-10 Cardiac disease treatment and device
US13625727 US20130184519A1 (en) 1998-07-13 2012-09-24 Cardiac support device with differential compliance

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09565621 Continuation US6537203B1 (en) 1998-07-13 2000-05-04 Cardiac disease treatment and device

Related Child Applications (5)

Application Number Title Priority Date Filing Date
US10251193 Continuation US6896652B2 (en) 1998-07-13 2002-09-20 Cardiac disease treatment and device
US10809962 Continuation US7578784B2 (en) 1998-07-13 2004-03-26 Cardiac support device with differential expansion
US10810096 Continuation US7153258B2 (en) 1998-07-13 2004-03-26 Cardiac support disease with anti-fibrosis coating
US10809961 Continuation US7025719B2 (en) 1998-07-13 2004-03-26 Metallic cardiac support device
US10810133 Continuation US20040181125A1 (en) 1998-07-13 2004-03-26 Cardiac disease treatment and device

Publications (1)

Publication Number Publication Date
US20010029314A1 true true US20010029314A1 (en) 2001-10-11

Family

ID=43063443

Family Applications (17)

Application Number Title Priority Date Filing Date
US09114510 Active US6123662A (en) 1998-07-13 1998-07-13 Cardiac disease treatment and device
US09565621 Active US6537203B1 (en) 1998-07-13 2000-05-04 Cardiac disease treatment and device
US09880576 Abandoned US20010029314A1 (en) 1998-07-13 2001-06-13 Cardiac disease treatment and device
US10251193 Active US6896652B2 (en) 1998-07-13 2002-09-20 Cardiac disease treatment and device
US10794311 Active US6997865B2 (en) 1998-07-13 2004-03-05 Cardiac support device with anti-fibrosis lining
US10794319 Active US7022064B2 (en) 1998-07-13 2004-03-05 Cardiac support with controlled ventricular pressure
US10809961 Active US7025719B2 (en) 1998-07-13 2004-03-26 Metallic cardiac support device
US10809962 Active US7578784B2 (en) 1998-07-13 2004-03-26 Cardiac support device with differential expansion
US10810096 Active US7153258B2 (en) 1998-07-13 2004-03-26 Cardiac support disease with anti-fibrosis coating
US10810133 Abandoned US20040181125A1 (en) 1998-07-13 2004-03-26 Cardiac disease treatment and device
US11329808 Active 2021-05-01 US7651461B2 (en) 1998-07-13 2006-01-10 Cardiac support with metallic structure
US11451209 Active 2019-03-18 US7575547B2 (en) 1998-07-13 2006-06-12 Cardiac support device with anti-fibrosis coating
US11469224 Abandoned US20070004962A1 (en) 1996-10-02 2006-08-31 Cardiac support device with differential compliance
US12633434 Abandoned US20100076256A1 (en) 1998-07-13 2009-12-08 Cardiac disease treatment and device
US12719553 Active US8277372B2 (en) 1996-10-02 2010-03-08 Cardiac support device with differential compliance
US12987430 Abandoned US20110106193A1 (en) 1998-07-13 2011-01-10 Cardiac disease treatment and device
US13625727 Abandoned US20130184519A1 (en) 1996-10-02 2012-09-24 Cardiac support device with differential compliance

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09114510 Active US6123662A (en) 1998-07-13 1998-07-13 Cardiac disease treatment and device
US09565621 Active US6537203B1 (en) 1998-07-13 2000-05-04 Cardiac disease treatment and device

Family Applications After (14)

Application Number Title Priority Date Filing Date
US10251193 Active US6896652B2 (en) 1998-07-13 2002-09-20 Cardiac disease treatment and device
US10794311 Active US6997865B2 (en) 1998-07-13 2004-03-05 Cardiac support device with anti-fibrosis lining
US10794319 Active US7022064B2 (en) 1998-07-13 2004-03-05 Cardiac support with controlled ventricular pressure
US10809961 Active US7025719B2 (en) 1998-07-13 2004-03-26 Metallic cardiac support device
US10809962 Active US7578784B2 (en) 1998-07-13 2004-03-26 Cardiac support device with differential expansion
US10810096 Active US7153258B2 (en) 1998-07-13 2004-03-26 Cardiac support disease with anti-fibrosis coating
US10810133 Abandoned US20040181125A1 (en) 1998-07-13 2004-03-26 Cardiac disease treatment and device
US11329808 Active 2021-05-01 US7651461B2 (en) 1998-07-13 2006-01-10 Cardiac support with metallic structure
US11451209 Active 2019-03-18 US7575547B2 (en) 1998-07-13 2006-06-12 Cardiac support device with anti-fibrosis coating
US11469224 Abandoned US20070004962A1 (en) 1996-10-02 2006-08-31 Cardiac support device with differential compliance
US12633434 Abandoned US20100076256A1 (en) 1998-07-13 2009-12-08 Cardiac disease treatment and device
US12719553 Active US8277372B2 (en) 1996-10-02 2010-03-08 Cardiac support device with differential compliance
US12987430 Abandoned US20110106193A1 (en) 1998-07-13 2011-01-10 Cardiac disease treatment and device
US13625727 Abandoned US20130184519A1 (en) 1996-10-02 2012-09-24 Cardiac support device with differential compliance

Country Status (1)

Country Link
US (17) US6123662A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537198B1 (en) 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US6746471B2 (en) 1998-07-29 2004-06-08 Myocor, Inc. Transventricular implant tools and devices
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US6808488B2 (en) 1998-09-21 2004-10-26 Myocor, Inc. External stress reduction device and method
US20050107661A1 (en) * 2000-03-10 2005-05-19 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US7666224B2 (en) 2002-11-12 2010-02-23 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7695425B2 (en) 1997-01-02 2010-04-13 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US7736299B2 (en) 2002-11-15 2010-06-15 Paracor Medical, Inc. Introducer for a cardiac harness delivery
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US7976454B2 (en) 2002-01-07 2011-07-12 Paracor Medical, Inc. Cardiac harness
US8092367B2 (en) 2001-09-07 2012-01-10 Mardil, Inc. Method for external stabilization of the base of the heart
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer
US8226711B2 (en) 1997-12-17 2012-07-24 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US8439817B2 (en) 1998-07-29 2013-05-14 Edwards Lifesciences, Llc Chordae capturing methods for stress reduction
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592619B2 (en) 1996-01-02 2003-07-15 University Of Cincinnati Heart wall actuation device for the natural heart
US20060217774A1 (en) * 1996-08-19 2006-09-28 Mower Morton M Cardiac contractile augmentation device and method therefor
US6406420B1 (en) * 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6045497A (en) 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US6123662A (en) * 1998-07-13 2000-09-26 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6587734B2 (en) * 1998-11-04 2003-07-01 Acorn Cardiovascular, Inc. Cardio therapeutic heart sack
US6695768B1 (en) * 1999-03-30 2004-02-24 Robert A. Levine Adjustable periventricular ring/ring like device/method for control of ischemic mitral regurgitation and congestive heart disease
DE60007257D1 (en) * 1999-10-21 2004-01-29 Univ Pohang A process for preparing cucurbituril derivatives
US6702732B1 (en) 1999-12-22 2004-03-09 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6293906B1 (en) 2000-01-14 2001-09-25 Acorn Cardiovascular, Inc. Delivery of cardiac constraint jacket
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US7011682B2 (en) 2000-01-31 2006-03-14 Edwards Lifesciences Ag Methods and apparatus for remodeling an extravascular tissue structure
US7510576B2 (en) 2001-01-30 2009-03-31 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6425856B1 (en) 2000-05-10 2002-07-30 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US20030023132A1 (en) * 2000-05-31 2003-01-30 Melvin David B. Cyclic device for restructuring heart chamber geometry
US7618364B2 (en) * 2000-06-12 2009-11-17 Acorn Cardiovascular, Inc. Cardiac wall tension relief device and method
US6730016B1 (en) * 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6902522B1 (en) 2000-06-12 2005-06-07 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US20050095268A1 (en) * 2000-06-12 2005-05-05 Acorn Cardiovascular, Inc. Cardiac wall tension relief with cell loss management
US6951534B2 (en) 2000-06-13 2005-10-04 Acorn Cardiovascular, Inc. Cardiac support device
US6482146B1 (en) * 2000-06-13 2002-11-19 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6572533B1 (en) * 2000-08-17 2003-06-03 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6808483B1 (en) 2000-10-03 2004-10-26 Paul A. Spence Implantable heart assist devices and methods
US6755779B2 (en) * 2000-12-01 2004-06-29 Acorn Cardiovascular, Inc. Apparatus and method for delivery of cardiac constraint jacket
US6622730B2 (en) 2001-03-30 2003-09-23 Myocor, Inc. Device for marking and aligning positions on the heart
US6923646B2 (en) * 2001-04-18 2005-08-02 Air Techniques, Inc. Process and apparatus for treating an exhaust stream from a dental operatory
EP1424958A2 (en) * 2001-09-10 2004-06-09 Paracor Medical, Inc. Cardiac harness
US7060023B2 (en) 2001-09-25 2006-06-13 The Foundry Inc. Pericardium reinforcing devices and methods of using them
US6695769B2 (en) 2001-09-25 2004-02-24 The Foundry, Inc. Passive ventricular support devices and methods of using them
US6685620B2 (en) 2001-09-25 2004-02-03 The Foundry Inc. Ventricular infarct assist device and methods for using it
JP2005507706A (en) * 2001-10-31 2005-03-24 パラコー メディカル インコーポレイテッド Heart failure therapy device
EP2181668A1 (en) * 2001-12-28 2010-05-05 Edwards Lifesciences AG Device for treating mitral annulus dilatation comprising a balloon catheter and a stent
US7174896B1 (en) 2002-01-07 2007-02-13 Paracor Medical, Inc. Method and apparatus for supporting a heart
US20040010180A1 (en) * 2002-05-16 2004-01-15 Scorvo Sean K. Cardiac assist system
US20030229260A1 (en) * 2002-06-05 2003-12-11 Acorn Cardiovascular, Inc. Cardiac support device with tension indicator
US20030229261A1 (en) * 2002-06-06 2003-12-11 Acorn Cardiovascular, Inc. Cardiac support devices and methods of producing same
US6682475B2 (en) 2002-06-11 2004-01-27 Acorn Cardiovascular, Inc. Tension indicator for cardiac support device and method therefore
US20030233022A1 (en) * 2002-06-12 2003-12-18 Vidlund Robert M. Devices and methods for heart valve treatment
US7081084B2 (en) * 2002-07-16 2006-07-25 University Of Cincinnati Modular power system and method for a heart wall actuation system for the natural heart
US7850729B2 (en) 2002-07-18 2010-12-14 The University Of Cincinnati Deforming jacket for a heart actuation device
US6988982B2 (en) * 2002-08-19 2006-01-24 Cardioenergetics Heart wall actuation system for the natural heart with shape limiting elements
US7346705B2 (en) * 2002-08-28 2008-03-18 Apple Inc. Method of synchronising three or more electronic devices and a computer system for implementing that method
EP1534173A2 (en) * 2002-09-05 2005-06-01 Paracor Medical, Inc. Cardiac harness
US20060178551A1 (en) * 2003-06-09 2006-08-10 Melvin David B Securement system for a heart actuation device
US20040059180A1 (en) * 2002-09-23 2004-03-25 The University Of Cincinnati Basal mounting cushion frame component to facilitate extrinsic heart wall actuation
US7247134B2 (en) * 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
EP1560541A2 (en) * 2002-11-15 2005-08-10 Paracor Medical, Inc. Cardiac harness delivery device
US20070255093A1 (en) * 2002-11-15 2007-11-01 Lilip Lau Cardiac harness delivery device and method
US7229405B2 (en) * 2002-11-15 2007-06-12 Paracor Medical, Inc. Cardiac harness delivery device and method of use
US20050059855A1 (en) * 2002-11-15 2005-03-17 Lilip Lau Cardiac harness delivery device and method
US7883500B2 (en) * 2003-03-26 2011-02-08 G&L Consulting, Llc Method and system to treat and prevent myocardial infarct expansion
US20050283042A1 (en) * 2003-03-28 2005-12-22 Steve Meyer Cardiac harness having radiopaque coating and method of use
US20040249242A1 (en) * 2003-03-28 2004-12-09 Lilip Lau Multi-panel cardiac harness
US7341584B1 (en) 2003-05-30 2008-03-11 Thomas David Starkey Device and method to limit filling of the heart
WO2004110257A3 (en) 2003-06-09 2005-08-04 Univ Cincinnati Power system for a heart actuation device
WO2004110553A1 (en) 2003-06-09 2004-12-23 The University Of Cincinnati Actuation mechanisms for a heart actuation device
EP1648333A2 (en) * 2003-07-10 2006-04-26 Paracor Medical, Inc. Self-anchoring cardiac harness
US20060009675A1 (en) * 2004-07-08 2006-01-12 Steven Meyer Self-anchoring cardiac harness for treating the heart and for defibrillating and/or pacing/sensing
US7235042B2 (en) * 2003-09-16 2007-06-26 Acorn Cardiovascular, Inc. Apparatus and method for applying cardiac support device
US20050171589A1 (en) * 2003-11-07 2005-08-04 Lilip Lau Cardiac harness and method of delivery by minimally invasive access
US20070055091A1 (en) * 2004-12-02 2007-03-08 Lilip Lau Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20050137673A1 (en) * 2003-11-07 2005-06-23 Lilip Lau Cardiac harness having electrodes and epicardial leads
US7155295B2 (en) * 2003-11-07 2006-12-26 Paracor Medical, Inc. Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20070106359A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
US7158839B2 (en) * 2003-11-07 2007-01-02 Paracor Medical, Inc. Cardiac harness for treating heart disease
US20070106336A1 (en) * 2003-11-07 2007-05-10 Alan Schaer Cardiac harness assembly for treating congestive heart failure and for pacing/sensing
CA2553185A1 (en) * 2004-01-12 2005-08-04 Paracor Medical, Inc. Cardiac harness having interconnected strands
US7297104B2 (en) * 2004-03-01 2007-11-20 John Vanden Hoek Seam closure device and methods
US7758491B2 (en) * 2004-04-05 2010-07-20 Genesee Biomedical, Inc. Method and apparatus for the surgical treatment of congestive heart failure
WO2006055820A3 (en) * 2004-11-19 2007-07-26 Ary Chernomorsky Biodegradable pericardial constraint system and method
US20060129026A1 (en) * 2004-12-15 2006-06-15 Joshua Wallin Apparatus and method for mounting a cardiac harness on the heart
US20060189840A1 (en) * 2005-02-18 2006-08-24 Acorn Cardiovascular, Inc. Transmyocardial delivery of cardiac wall tension relief
US20060247491A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for heart valve treatment
US20060247672A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for pericardial access
US7621866B2 (en) * 2005-05-31 2009-11-24 Ethicon, Inc. Method and device for deployment of a sub-pericardial sack
US20070032696A1 (en) * 2005-07-22 2007-02-08 Sieu Duong Cardiac harness delivery device
US7587247B2 (en) * 2005-08-01 2009-09-08 Paracor Medical, Inc. Cardiac harness having an optimal impedance range
US7715918B2 (en) 2005-10-18 2010-05-11 University Of Cincinnati Muscle energy converter with smooth continuous tissue interface
US7727142B2 (en) * 2006-03-03 2010-06-01 Acorn Cardiovascular, Inc. Delivery tool for cardiac support device
US20070208217A1 (en) 2006-03-03 2007-09-06 Acorn Cardiovascular, Inc. Self-adjusting attachment structure for a cardiac support device
US20070270654A1 (en) * 2006-05-19 2007-11-22 Acorn Cardiovascular, Inc. Pericardium management tool for intra-pericardial surgical procedures
US20070287883A1 (en) * 2006-06-07 2007-12-13 Lilip Lau Apparatus and method for pulling a cardiac harness onto a heart
US20080004488A1 (en) * 2006-06-29 2008-01-03 Acorn Cardiovascular, Inc. Low friction delivery tool for a cardiac support device
US7651462B2 (en) 2006-07-17 2010-01-26 Acorn Cardiovascular, Inc. Cardiac support device delivery tool with release mechanism
US7641608B1 (en) 2006-09-26 2010-01-05 Acorn Cardiovascular, Inc. Sectional cardiac support device and method of delivery
US20080091057A1 (en) * 2006-10-11 2008-04-17 Cardiac Pacemakers, Inc. Method and apparatus for passive left atrial support
US8718746B2 (en) * 2007-06-21 2014-05-06 Mardil, Inc. Pericardial space imaging for cardiac support device implantation
US20090048480A1 (en) * 2007-08-13 2009-02-19 Paracor Medical, Inc. Cardiac harness delivery device
US8092363B2 (en) 2007-09-05 2012-01-10 Mardil, Inc. Heart band with fillable chambers to modify heart valve function
US20090177028A1 (en) * 2008-01-04 2009-07-09 Anthony John White Non-blood contact cardiac compression device, for augmentation of cardiac function by timed cyclic tensioning of elastic cords in an epicardial location
US20090281372A1 (en) * 2008-05-06 2009-11-12 Paracor Medical, Inc. Cardiac harness assembly for treating congestive heart failure and for defibrillation and/or pacing/sensing
US8795149B2 (en) 2010-11-23 2014-08-05 Theodore J. Lillehei Pneumatic or hydraulic cardiac assist devices
WO2014059433A3 (en) 2012-10-12 2014-06-19 Mardil, Inc. Cardiac treatment system and method
USD717954S1 (en) 2013-10-14 2014-11-18 Mardil, Inc. Heart treatment device

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336253A (en) * 1993-02-23 1994-08-09 Medtronic, Inc. Pacing and cardioversion lead systems with shared lead conductors
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5593428A (en) * 1993-09-27 1997-01-14 Khosrow Jamshidi Emergency external cardiac defibrillator and pacing method and apparatus
US6224540B1 (en) * 1995-06-13 2001-05-01 Abiomed, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US6537203B1 (en) * 1998-07-13 2003-03-25 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6564094B2 (en) * 2000-12-22 2003-05-13 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6567699B2 (en) * 1998-11-18 2003-05-20 Acorn Cardiovascular, Inc. Defibrillating cardiac constraint

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US524633A (en) * 1894-08-14 And gotthold
US1682119A (en) * 1928-08-28 Cleaning device
US1965542A (en) * 1933-11-24 1934-07-03 Jr William Colvin Fabric
US2138603A (en) * 1936-10-06 1938-11-29 Du Pont Explosive package
US2278926A (en) * 1941-02-15 1942-04-07 Metal Textile Corp Knitted metallic fabric for belting and other uses
US2376442A (en) * 1943-07-07 1945-05-22 Mehler Hugo Tubular netting
US2376926A (en) * 1943-12-22 1945-05-29 United Last Company Shoe tree
US2955961A (en) * 1958-01-24 1960-10-11 Du Pont Process of coating polyethylene terephthalate substrate with a polyurethane and resultant article
US2992550A (en) * 1959-05-13 1961-07-18 Hagin Frith & Sons Knitted mesh
US3138156A (en) * 1961-12-05 1964-06-23 Surgical Appliance Ind Stump shrinker
US3200619A (en) * 1963-07-05 1965-08-17 Hagin Frith & Sons Triple-stitch joint for knitted mesh
GB1113423A (en) * 1964-07-31 1968-05-15 Plastic Textile Access Ltd Improvements in or relating to extruded plastic net
US3460896A (en) * 1964-10-14 1969-08-12 Eastman Kodak Co Polyester fibers having improved hydrophilicity as a result of modification with phosphoric acid,phosphorous acid or perchloric acid
FR1483847A (en) * 1966-04-08 1967-06-09 Knitted protection to be worn under a prosthetic device or orthopedic and article manufacturing process
US3452740A (en) * 1966-05-31 1969-07-01 Us Catheter & Instr Corp Spring guide manipulator
US3551543A (en) * 1967-09-06 1970-12-29 Plastic Textile Access Ltd Manufacture of plastic net
US3587567A (en) * 1968-12-20 1971-06-28 Peter Paul Schiff Mechanical ventricular assistance assembly
US3768643A (en) * 1971-07-27 1973-10-30 Manetti M Nestable net produce bag and carrier therefor
US3732662A (en) * 1971-07-30 1973-05-15 F Paxton Method of forming, filling, closing and labelling tubular netting bags
US3811411A (en) * 1973-01-02 1974-05-21 H Moeller Method of cultivating mollusks
US3983863A (en) * 1975-06-02 1976-10-05 American Hospital Supply Corporation Heart support for coronary artery surgery
US4048990A (en) * 1976-09-17 1977-09-20 Goetz Robert H Heart massage apparatus
US4196534A (en) * 1977-10-27 1980-04-08 Toshitsune Shibamoto Plastic net bag and label
US4428375A (en) * 1982-02-16 1984-01-31 Ellman Barry R Surgical bag for splenorrhaphy
US4403604A (en) * 1982-05-13 1983-09-13 Wilkinson Lawrence H Gastric pouch
US4466331A (en) * 1983-06-06 1984-08-21 Redden Net Co., Inc. Method of forming twisted multiple strand synthetic twine, twines produced thereby, and fishnets formed thereof
US4508103A (en) * 1983-09-06 1985-04-02 Calisi Constance M Pressure monitoring interconnect system
JPS60203250A (en) * 1984-03-29 1985-10-14 Nippon Zeon Co Patch for heart operation
US4630597A (en) * 1984-04-30 1986-12-23 Adrian Kantrowitz Dynamic aortic patch for thoracic or abdominal implantation
US4567900A (en) 1984-06-04 1986-02-04 Moore J Paul Internal deployable defibrillator electrode
US4690134A (en) * 1985-07-01 1987-09-01 Snyders Robert V Ventricular assist device
US4637377A (en) * 1985-09-20 1987-01-20 Loop Floyd D Pillow or support member for surgical use
US4731084A (en) * 1986-03-14 1988-03-15 Richards Medical Company Prosthetic ligament
US4638648A (en) * 1986-05-01 1987-01-27 E. I. Du Pont De Nemours And Company Layered warp knits
JPH0362820B2 (en) * 1986-05-08 1991-09-27 Kuraray Co
DK163344C (en) * 1986-05-22 1992-07-13 Astra Tech Ab Heart Relief Device
US4840635A (en) * 1986-08-08 1989-06-20 Knit-Rite, Inc. Full-fashion stump shrinker for the residual limb of a human amputee
FR2605214B1 (en) * 1986-10-15 1992-01-10 Ethnor Prothese perihepatic
US4808675A (en) * 1986-12-22 1989-02-28 Allied-Signal Inc. Moisture permeable film for lamination to a textile material
US4936857A (en) * 1987-02-23 1990-06-26 Kulik Yaroslav P Prosthetic pericardium
US4821723A (en) * 1987-02-27 1989-04-18 Intermedics Inc. Biphasic waveforms for defibrillation
US4827932A (en) * 1987-02-27 1989-05-09 Intermedics Inc. Implantable defibrillation electrodes
US4834707A (en) * 1987-09-16 1989-05-30 Evans Phillip H Venting apparatus and method for cardiovascular pumping application
US4976730A (en) * 1988-10-11 1990-12-11 Kwan Gett Clifford S Artificial pericardium
US5188813A (en) * 1988-10-12 1993-02-23 Johnson Matthey Public Limited Company Metal fabrics
US5224363A (en) * 1988-12-16 1993-07-06 Golden Needles Knitting & Glove Co., Inc. Method of making garment, garment, and strand material
US5186711A (en) * 1989-03-07 1993-02-16 Albert Einstein College Of Medicine Of Yeshiva University Hemostasis apparatus and method
US4995857A (en) * 1989-04-07 1991-02-26 Arnold John R Left ventricular assist device and method for temporary and permanent procedures
JPH02271829A (en) 1989-04-13 1990-11-06 Tanaka Kikinzoku Kogyo Kk Electrode for deciding myocardial infarction
US5057117A (en) * 1989-04-27 1991-10-15 The Research Foundation Of State University Of New York Method and apparatus for hemostasis and compartmentalization of a bleeding internal bodily organ
JP3009912B2 (en) * 1989-07-07 2000-02-14 旭化成工業株式会社 Alkali metal chloride electrolysis the cation exchange membrane
US4973300A (en) * 1989-09-22 1990-11-27 Pioneering Technologies, Inc. Cardiac sling for circumflex coronary artery surgery
US5074129A (en) * 1989-12-26 1991-12-24 Novtex Formable fabric
US5087243A (en) * 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
WO1992008500A1 (en) * 1990-11-09 1992-05-29 Mcgill University Cardiac assist method and apparatus
US5207725A (en) * 1991-03-05 1993-05-04 Pinkerton Linda L Soap holder
US5150706A (en) * 1991-08-15 1992-09-29 Cox James L Cooling net for cardiac or transplant surgery
US5290217A (en) * 1991-10-10 1994-03-01 Earl K. Sipes Method and apparatus for hernia repair
US5524633A (en) * 1991-11-25 1996-06-11 Advanced Surgical, Inc. Self-deploying isolation bag
WO1993019678A3 (en) * 1991-12-03 1993-12-23 Vesitec Medical Inc Surgical treatment of stress urinary incontinence
US5192314A (en) * 1991-12-12 1993-03-09 Daskalakis Michael K Synthetic intraventricular implants and method of inserting
US5307522A (en) * 1992-02-07 1994-05-03 James L. Throneburg Snowboarding sock
CA2089999A1 (en) 1992-02-24 1993-08-25 H. Jonathan Tovey Resilient arm mesh deployer
WO1993017635A1 (en) * 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
US5383840A (en) * 1992-07-28 1995-01-24 Vascor, Inc. Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly
US5279539A (en) * 1992-08-17 1994-01-18 Ethicon, Inc. Drawstring surgical pouch and method of use for preventing ovarian adhesions
US5256132A (en) * 1992-08-17 1993-10-26 Snyders Robert V Cardiac assist envelope for endoscopic application
US5339657A (en) * 1992-09-01 1994-08-23 Mcmurray Fabrics, Inc. Net having different size openings and method of making
DE4300791A1 (en) * 1993-01-14 1994-07-21 Heraeus Gmbh W C Knitted fabric of wires containing precious metal and process for its preparation
US5356432B1 (en) * 1993-02-05 1997-02-04 Bard Inc C R Implantable mesh prosthesis and method for repairing muscle or tissue wall defects
US5735290A (en) * 1993-02-22 1998-04-07 Heartport, Inc. Methods and systems for performing thoracoscopic coronary bypass and other procedures
US5450706A (en) * 1993-05-24 1995-09-19 Latini Machine Company, Inc. Single twist bunch wrapping machine
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5385156A (en) * 1993-08-27 1995-01-31 Rose Health Care Systems Diagnostic and treatment method for cardiac rupture and apparatus for performing the same
US5507779A (en) * 1994-04-12 1996-04-16 Ventritex, Inc. Cardiac insulation for defibrillation
US5749839A (en) * 1994-08-18 1998-05-12 Duke University Direct mechanical bi-ventricular cardiac assist device
US5738627A (en) * 1994-08-18 1998-04-14 Duke University Bi-ventricular cardiac assist device
US6331188B1 (en) * 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US5603337A (en) * 1994-12-05 1997-02-18 Jarvik; Robert Two-stage cardiomyoplasty
US5647380A (en) * 1995-06-07 1997-07-15 W. L. Gore & Associates, Inc. Method of making a left ventricular assist device
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
DE29517393U1 (en) * 1995-11-03 1996-02-01 Hohmann Claas Dr Med Pericardial prosthesis
US5782746A (en) * 1996-02-15 1998-07-21 Wright; John T. M. Local cardiac immobilization surgical device
US5979322A (en) * 1996-05-07 1999-11-09 Demoore; Howard Warren Environmentally safe, ink repellent, anti-marking flexible jacket covering having alignment stripes, centering marks and pre-fabricated reinforcement strips for attachment onto transfer cylinders in a printing press
US5766216A (en) * 1996-05-30 1998-06-16 Gangal; Hanamraddi T. Band applicator for appendicular and meso-appendicular stumps
US5702343A (en) * 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US6206004B1 (en) * 1996-12-06 2001-03-27 Comedicus Incorporated Treatment method via the pericardial space
US6127556A (en) * 1996-12-31 2000-10-03 G. D. Searle & Co. Epoxide formation by continuous in-situ synthesis process
US6050936A (en) * 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US6045497A (en) * 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
JP3134287B2 (en) * 1997-01-30 2001-02-13 株式会社ニッショー Intracardiac suture surgery for catheter assembly
CA2250728A1 (en) * 1997-02-07 1998-08-13 Olaechea Rosalina Paniagua Process for closing nets for fruits and the like and net closed by means of said process
EP0991373B1 (en) 1997-06-21 2004-09-15 Acorn Cardiovascular, Inc. Bag for at least partially enveloping a heart
US5839842A (en) * 1998-02-05 1998-11-24 Lever Brothers Company, Division Of Conopco, Inc. Cleansing system including a toilet bar and sponge supported within a porous pouch
US6095968A (en) * 1998-04-10 2000-08-01 Cardio Technologies, Inc. Reinforcement device
US6085754A (en) * 1998-07-13 2000-07-11 Acorn Cardiovascular, Inc. Cardiac disease treatment method
US6077214A (en) * 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6360749B1 (en) * 1998-10-09 2002-03-26 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US6230714B1 (en) * 1998-11-18 2001-05-15 Acorn Cardiovascular, Inc. Cardiac constraint with prior venus occlusion methods
US6076013A (en) 1999-01-14 2000-06-13 Brennan; Edward F. Apparatus and methods for treating congestive heart failure
US6241654B1 (en) * 1999-07-07 2001-06-05 Acorn Cardiovasculr, Inc. Cardiac reinforcement devices and methods
US6569082B1 (en) * 1999-08-10 2003-05-27 Origin Medsystems, Inc. Apparatus and methods for cardiac restraint
US6174279B1 (en) * 1999-09-21 2001-01-16 Acorn Cardiovascular, Inc. Cardiac constraint with tension indicator
US6193648B1 (en) * 1999-09-21 2001-02-27 Acorn Cardiovascular, Inc. Cardiac constraint with draw string tensioning
US6179791B1 (en) * 1999-09-21 2001-01-30 Acorn Cardiovascular, Inc. Device for heart measurement
US6541678B2 (en) * 1999-09-27 2003-04-01 Brennen Medical, Inc. Immunostimulating coating for surgical devices
US6702732B1 (en) * 1999-12-22 2004-03-09 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
CA2402504A1 (en) * 2000-03-10 2001-09-20 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6293906B1 (en) * 2000-01-14 2001-09-25 Acorn Cardiovascular, Inc. Delivery of cardiac constraint jacket
US6425856B1 (en) * 2000-05-10 2002-07-30 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6730016B1 (en) * 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6902522B1 (en) * 2000-06-12 2005-06-07 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6482146B1 (en) * 2000-06-13 2002-11-19 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6572533B1 (en) * 2000-08-17 2003-06-03 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6673009B1 (en) * 2000-11-08 2004-01-06 Acorn Cardiovascular, Inc. Adjustment clamp
US6755779B2 (en) * 2000-12-01 2004-06-29 Acorn Cardiovascular, Inc. Apparatus and method for delivery of cardiac constraint jacket
EP1424958A2 (en) * 2001-09-10 2004-06-09 Paracor Medical, Inc. Cardiac harness
US7060023B2 (en) * 2001-09-25 2006-06-13 The Foundry Inc. Pericardium reinforcing devices and methods of using them
US6695769B2 (en) * 2001-09-25 2004-02-24 The Foundry, Inc. Passive ventricular support devices and methods of using them
JP2005507706A (en) * 2001-10-31 2005-03-24 パラコー メディカル インコーポレイテッド Heart failure therapy device
US6682475B2 (en) * 2002-06-11 2004-01-27 Acorn Cardiovascular, Inc. Tension indicator for cardiac support device and method therefore
EP1560541A2 (en) * 2002-11-15 2005-08-10 Paracor Medical, Inc. Cardiac harness delivery device
US20050059855A1 (en) * 2002-11-15 2005-03-17 Lilip Lau Cardiac harness delivery device and method
US7235042B2 (en) * 2003-09-16 2007-06-26 Acorn Cardiovascular, Inc. Apparatus and method for applying cardiac support device
US20060009831A1 (en) * 2003-11-07 2006-01-12 Lilip Lau Cardiac harness having leadless electrodes for pacing and sensing therapy

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336253A (en) * 1993-02-23 1994-08-09 Medtronic, Inc. Pacing and cardioversion lead systems with shared lead conductors
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5593428A (en) * 1993-09-27 1997-01-14 Khosrow Jamshidi Emergency external cardiac defibrillator and pacing method and apparatus
US6224540B1 (en) * 1995-06-13 2001-05-01 Abiomed, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US6508756B1 (en) * 1995-06-13 2003-01-21 Abiomed, Inc. Passive cardiac assistance device
US6537203B1 (en) * 1998-07-13 2003-03-25 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6567699B2 (en) * 1998-11-18 2003-05-20 Acorn Cardiovascular, Inc. Defibrillating cardiac constraint
US6564094B2 (en) * 2000-12-22 2003-05-13 Acorn Cardiovascular, Inc. Cardiac disease treatment and device

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8267852B2 (en) 1997-01-02 2012-09-18 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US8460173B2 (en) 1997-01-02 2013-06-11 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US7695425B2 (en) 1997-01-02 2010-04-13 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US8226711B2 (en) 1997-12-17 2012-07-24 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US6746471B2 (en) 1998-07-29 2004-06-08 Myocor, Inc. Transventricular implant tools and devices
US8439817B2 (en) 1998-07-29 2013-05-14 Edwards Lifesciences, Llc Chordae capturing methods for stress reduction
US7722523B2 (en) 1998-07-29 2010-05-25 Edwards Lifesciences Llc Transventricular implant tools and devices
US7981020B2 (en) 1998-07-29 2011-07-19 Edwards Lifesciences Llc Transventricular implant tools and devices
US6808488B2 (en) 1998-09-21 2004-10-26 Myocor, Inc. External stress reduction device and method
US8579798B2 (en) 1998-09-21 2013-11-12 Edwards Lifesciences, Llc External cardiac stress reduction method
US7276022B2 (en) 2000-03-10 2007-10-02 Paracor Medical, Inc. Expandable cardiac harness for treating congestive heart failure
US20050107661A1 (en) * 2000-03-10 2005-05-19 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US7238152B2 (en) 2000-03-10 2007-07-03 Paracor Medical, Inc. Self-adjusting expandable cardiac harness for treating congestive heart failure
US6537198B1 (en) 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US7766812B2 (en) 2000-10-06 2010-08-03 Edwards Lifesciences Llc Methods and devices for improving mitral valve function
US9198757B2 (en) 2000-10-06 2015-12-01 Edwards Lifesciences, Llc Methods and devices for improving mitral valve function
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US8715160B2 (en) 2001-09-07 2014-05-06 Mardil, Inc. Method and apparatus for external stabilization of the heart
US8092367B2 (en) 2001-09-07 2012-01-10 Mardil, Inc. Method for external stabilization of the base of the heart
US8128553B2 (en) 2001-09-07 2012-03-06 Mardil, Inc. Method and apparatus for external stabilization of the heart
US9289298B2 (en) 2001-09-07 2016-03-22 Mardil, Inc. Method and apparatus for external stabilization of the heart
US7976454B2 (en) 2002-01-07 2011-07-12 Paracor Medical, Inc. Cardiac harness
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment
US8070805B2 (en) 2002-01-09 2011-12-06 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7678145B2 (en) 2002-01-09 2010-03-16 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7666224B2 (en) 2002-11-12 2010-02-23 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7736299B2 (en) 2002-11-15 2010-06-15 Paracor Medical, Inc. Introducer for a cardiac harness delivery
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer

Also Published As

Publication number Publication date Type
US20130184519A1 (en) 2013-07-18 application
US20040181122A1 (en) 2004-09-16 application
US20060235265A1 (en) 2006-10-19 application
US20040181123A1 (en) 2004-09-16 application
US6997865B2 (en) 2006-02-14 grant
US7153258B2 (en) 2006-12-26 grant
US20030028077A1 (en) 2003-02-06 application
US20040171907A1 (en) 2004-09-02 application
US20110106193A1 (en) 2011-05-05 application
US7025719B2 (en) 2006-04-11 grant
US20040171908A1 (en) 2004-09-02 application
US7022064B2 (en) 2006-04-04 grant
US7575547B2 (en) 2009-08-18 grant
US20100076256A1 (en) 2010-03-25 application
US7578784B2 (en) 2009-08-25 grant
US20070004962A1 (en) 2007-01-04 application
US20040181121A1 (en) 2004-09-16 application
US20060111607A1 (en) 2006-05-25 application
US8277372B2 (en) 2012-10-02 grant
US20100160721A1 (en) 2010-06-24 application
US6896652B2 (en) 2005-05-24 grant
US6123662A (en) 2000-09-26 grant
US7651461B2 (en) 2010-01-26 grant
US20040181125A1 (en) 2004-09-16 application
US6537203B1 (en) 2003-03-25 grant

Similar Documents

Publication Publication Date Title
US6045497A (en) Heart wall tension reduction apparatus and method
US6450171B1 (en) Anterior and inferior segment ventricular restoration apparatus and method
US5350420A (en) Flexible annuloplasty ring and holder
US6463332B1 (en) Method and system for pericardial enhancement
US7192443B2 (en) Delayed memory device
US20040176840A1 (en) Percutaneous mitral annuloplasty with hemodynamic monitoring
US20070203391A1 (en) System for Treating Mitral Valve Regurgitation
US6439237B1 (en) Anterior segment coronary restoration apparatus and method
US20040133062A1 (en) Minimally invasive cardiac force transfer structures
US20060069430A9 (en) Devices, systems, and methods for retaining a native heart valve leaflet
US20060025858A1 (en) Mitral valve ring for treatment of mitral valve regurgitation
US20030023132A1 (en) Cyclic device for restructuring heart chamber geometry
US7247134B2 (en) Devices and methods for heart valve treatment
US6508756B1 (en) Passive cardiac assistance device
US20030060677A1 (en) Passive ventricular support devices and methods of using them
US20070066879A1 (en) Body lumen shaping device with cardiac leads
US6723041B2 (en) Device for treating heart failure
US6077218A (en) Cardiac reinforcement device
US6902522B1 (en) Cardiac disease treatment and device
US6730016B1 (en) Cardiac disease treatment and device
US7291168B2 (en) Methods and devices for heart valve treatments
US20040015040A1 (en) Flexible, torsionable cardiac framework for heart wall actuation of the natural heart
US6976995B2 (en) Fixed length anchor and pull mitral valve device and method
US7063722B2 (en) Method of implanting a self-molding annuloplasty ring
US20060161169A1 (en) Device and method for modifying the shape of a body organ